Make multiple daily injections a thing of the past
Simplify diabetes with V-Go®
Insulin delivery that’s worn like a patch
Simple all-day-and-night insulin delivery patch you apply once daily
V-Go is designed to fit easily into your life and help you manage diabetes by combining all of your insulin needs into one simple device you apply like a patch. That’s right — no more insulin pens or syringes!
V-Go supplies insulin in two ways, similar to the way your body produces insulin:
• Provides a steady rate of background insulin over a 24-hour period
• Provides additional insulin at mealtimes without anyone knowing by discreetly clicking a button
By using V-Go, you can live your life on the go without interrupting your day to gather supplies or look for a private place to give yourself an injection.
Benefits of V-Go Insulin Delivery
Simple diabetes management*
• Control blood glucose 24/7
• Apply like a patch once a day
• More easily comply with your treatment regimen
• Deliver 20, 30 or 40 units of insulin in one 24-hour period and on-demand bolus dosing in 2-unit increments
Lower A1C while using less insulin as compared to multiple daily injections (MDIs)1,2
• No need to carry insulin pens, syringes or vials
So discreet, nobody will know you’re using it — even at mealtimes
• Mealtime insulin can be administered with a few simple clicks, over clothing*
• No batteries, tubes or programming
V-Go is reimbursed by many commercial insurances
• Only fast-acting insulin used — no need for long-acting insulin
• Many V-Go customers use insulin more efficiently, wasting less and using less, ultimately saving money
• No more copays for needles or syringes, saving even more money
Get Started with V-Go
If you have Type 2 diabetes and are taking multiple daily injections, the V-Go insulin delivery patch may be the perfect solution for you. Our Diabetes Care team focuses on personalized care and will walk you through the entire process. Just complete this form so that EHCS can connect you with your own dedicated Diabetes Care Coordinator who will work with you, your insurance company and your healthcare team to determine your eligibility for V-Go.
References 1. Harrison HC, Everitt B, Nikkel C. Poster: The Impact of utilizing a novel insulin delivery device in patients with type 2 diabetes. Presented at ACCE. May 2017. 2. Lajara R, Nikkel C. Poster: Evaluating the effect of V-Go® therapy in sub-optimally controlled patients with diabetes: a retrospective cohort analysis on a large specialized diabetes system. Presented at ACCE. May 2015. 3. Lajara R, Nikkel C. Poster presented at: the International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting; May 2017; Boston, MA.
Important Risk Information If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.